Cardiovascular autonomic dysfunction predicts diabetic foot ulcers in patients with type 2 diabetes without diabetic polyneuropathy

Medicine (United States)

Volumn 95, Issue 12, 2016, Pages

  Yun, Jae Seung ^a   Cha, Seon Ah ^a   Lim, Tae Seok ^a   Lee, Eun Young ^d   Song, Ki Ho ^e   Ahn, Yu Bae ^a   Yoo, Ki Dong ^b   Kim, Joon Sung ^c   Park, Yong Moon ^f   Ko, Seung Hyun ^a  

^a The Catholic University of Korea College of Medicine   (South Korea)

^b Division of Cardiology   (United States)

^c ST VINCENT S HOSPITAL   (Australia)

^d The Catholic University of Korea   (South Korea)

^e The Catholic University of Korea   (South Korea)

^f NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN;

ADULT; AGED; ARTICLE; AUTONOMIC DYSFUNCTION; CARDIOVASCULAR AUTONOMIC DYSFUNCTION; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIABETIC FOOT; DIABETIC NEUROPATHY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; FUNCTION TEST; HEART RATE VARIABILITY; HUMAN; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PRIORITY JOURNAL; AUTONOMIC NERVOUS SYSTEM DISEASES; DIABETIC NEUROPATHIES; HEART; HEART RATE; INNERVATION; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS; PROSPECTIVE STUDY; SOUTH KOREA;

ADULT; AGED; AUTONOMIC NERVOUS SYSTEM DISEASES; DIABETES MELLITUS, TYPE 2; DIABETIC FOOT; DIABETIC NEUROPATHIES; FEMALE; FOLLOW-UP STUDIES; HEART; HEART RATE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; REPUBLIC OF KOREA;

EID: 84962142248     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000003128     Document Type: Article

References (47)

1. van Battum P, Schaper N, Prompers L, et al. Differences in minor amputation rate in diabetic foot disease throughout Europe are in part explained by differences in disease severity at presentation. Diabet Med. 2011;28:199-205.
2. Boyko EJ, Ahroni JH, Smith DG, et al. Increased mortality associated with diabetic foot ulcer. Diabet Med. 1996;13:967-972.
3. Frykberg RG, Zgonis T, Armstrong DG, et al. Diabetic foot disorders. A clinical practice guideline (2006 revision). J Foot Ankle Surg. 2006;45(Suppl):S1-S66.
4. Lopez-de-Andres A, Martinez-Huedo MA, Carrasco-Garrido P, et al. Trends in lower-extremity amputations in people with and without diabetes in Spain, 2001-2008. Diabetes Care. 2011;34:1570-1576.
5. Vamos EP, Bottle A, Majeed A, et al. Trends in lower extremity amputations in people with and without diabetes in England, 1996-2005. Diabetes Res Clin Pract. 2010;87:275-282.
6. Boulton AJ, Armstrong DG, Albert SF, et al. Comprehensive foot examination and risk assessment: a report of the task force of the foot care interest group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinolo-gists. Diabetes Care. 2008;31:1679-1685.
7. Bruun C, Siersma V, Guassora AD, et al. Amputations and foot ulcers in patients newly diagnosed with type 2 diabetes mellitus and observed for 19 years. The role of age, gender and co-morbidity. Diabet Med. 2013;30:964-972.
8. Brownrigg JR, Davey J, Holt PJ, et al. The association of ulceration of the foot with cardiovascular and all-cause mortality in patients with diabetes: a meta-analysis. Diabetologia. 2012;55:2906-2912.
9. Kim SH, Lee KA, Jin HY, et al. Relationship between the Korean Version Survey of the Autonomic Symptoms Score and cardiac autonomic neuropathy parameters in patients with diabetic peripheral neuropathy. Diabetes Metab J. 2014;38:349-355.
10. Vinik AI, Maser RE, Mitchell BD, et al. Diabetic autonomic neuropathy. Diabetes Care. 2003;26:1553-1579.
11. Gilmore JE, Allen JA, Hayes JR. Autonomic function in neuropathic diabetic patients with foot ulceration. Diabetes Care. 1993;16:61-67.
12. Edmonds ME, Nicolaides KH, Watkins PJ. Autonomic neuropathy and diabetic foot ulceration. Diabet Med. 1986;3:56-59.
13. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461-470.
14. Ghanassia E, Villon L, Thuan Dit Dieudonne JF, et al. Long-term outcome and disability of diabetic patients hospitalized for diabetic foot ulcers: a 6.5-year follow-up study. Diabetes Care. 2008;31:1288-1292.
15. Yun JS, Ko SH, Ko SH, et al. Presence of macroalbuminuria predicts severe hypoglycemia in patients with type 2 diabetes: a 10-year follow-up study. Diabetes Care. 2013;36:1283-1289.
16. Tesfaye S, Stevens LK, Stephenson JM, et al. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia. 1996;39:1377-1384.
17. Yun JS, Ko SH, Ko SH, et al. Cardiovascular disease predicts severe hypoglycemia in patients with type 2 diabetes. Diabetes Metab J. 2015;39:498-506.
18. Tesfaye S, Boulton AJ, Dyck PJ, et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 2010;33:2285-2293.
19. Kuehl M, Stevens MJ. Cardiovascular autonomic neuropathies as complications of diabetes mellitus. Nat Rev Endocrinol. 2012;8: 405-416.
20. Noor S, Zubair M, Ahmad J. Diabetic foot ulcer-a review on pathophysiology, classification and microbial etiology. Diabetes Metab Syndr. 2015;9:192-199.
21. Centers for Disease Control and Prevention (CDC). National Hospital Discharge Survey. www.cdc.gov/diabetes/statistics/hospitali-zation-national.htm. Accessed September 17, 2015.
22. Ahmad N, Thomas GN, Chan C, et al. Ethnic differences in lower limb revascularisation and amputation rates. Implications for the aetiopathology of atherosclerosis? Atherosclerosis. 2014;233: 503-507.
23. Yang Y, Ostbye T, Tan SB, et al. Risk factors for lower extremity amputation among patients with diabetes in Singapore. J Diabetes Complications. 2011;25:382-386.
24. Chi ZS, Lee ET, Lu M, et al. Vascular disease prevalence in diabetic patients in China: standardised comparison with the 14 centres in the WHO Multinational Study of Vascular Disease in Diabetes. Diabeto-logia. 2001;44(Suppl 2):S82-S86.
25. Lee ET, Keen H, Bennett PH, et al. Follow-up of the WHO multinational study of vascular disease in diabetes: general description and morbidity. Diabetologia. 2001;44(Suppl 2):S3-S13.
26. Aleem MA. Factors that precipitate development of diabetic foot ulcers in rural India. Lancet. 2003;362:1858.
27. Mayfield JA, Reiber GE, Sanders LJ, et al. Preventive foot care in people with diabetes. Diabetes Care. 1998;21:2161-2177.
28. Aziz Z, Lin WK, Nather A, et al. Predictive factors for lower extremity amputations in diabetic foot infections. Diabet Foot Ankle. 2011;2. doi: 10.3402/dfa.v2i0.7463.
29. Ahmad J. The diabetic foot. Diabetes Metab Syndr. 2015. doi: 10.1016/j.dsx.2015.04.002.
30. Gardner SE, Frantz RA. Wound bioburden and infection-related complications in diabetic foot ulcers. Biol Res Nurs. 2008;10:44-53.
31. Young MJ, Breddy JL, Veves A, et al. The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds. A prospective study. Diabetes Care. 1994;17:557-560.
32. Abbott CA, Vileikyte L, Williamson S, et al. Multicenter study of the incidence of and predictive risk factors for diabetic neuropathic foot ulceration. Diabetes Care. 1998;21:1071-1075.
33. Boyko EJ, Ahroni JH, Stensel V, et al. A prospective study of risk factors for diabetic foot ulcer. The Seattle Diabetic Foot Study. Diabetes Care. 1999;22:1036-1042.
34. Boyko EJ, Ahroni JH, Cohen V, et al. Prediction of diabetic foot ulcer occurrence using commonly available clinical information: the Seattle Diabetic Foot Study. Diabetes Care. 2006;29:1202-1207.
35. Aso Y, Fujiwara Y, Inukai T, et al. Power spectral analysis of heart rate variation in diabetic patients with neuropathic foot ulceration. Diabetes Care. 1998;21:1173-1177.
36. Edmonds ME. The diabetic foot: pathophysiology and treatment. Clin Endocrinol Metab. 1986;15:889-916.
37. Kozniewska E, Jung L, Skolasinska K, et al. Changes in blood flow and permeability of vessels to protein preceding the development of cutaneous ulcers in the hind limb of the rabbit. Microvasc Res. 1980;19:189-196.
38. Takahashi T, Nishizawa Y, Emoto M, et al. Sympathetic function test of vasoconstrictor changes in foot arteries in diabetic patients. Diabetes Care. 1998;21:1495-1501.
39. Canani LH, Copstein E, Pecis M, et al. Cardiovascular autonomic neuropathy in type 2 diabetes mellitus patients with peripheral artery disease. Diabetol Metab Syndr. 2013;5:54.
40. Jaiswal M, Urbina EM, Wadwa RP, et al. Reduced heart rate variability is associated with increased arterial stiffness in youth with type 1 diabetes: the SEARCH CVD study. Diabetes Care. 2013;36:2351-2358.
41. Watanabe S, Amiya E, Watanabe M, et al. Simultaneous heart rate variability monitoring enhances the predictive value of flow-mediated dilation in ischemic heart disease. Circ J. 2013;77:1018-1025.
42. Gottsater A, Ahlgren AR, Taimour S, et al. Decreased heart rate variability may predict the progression of carotid atherosclerosis in type 2 diabetes. Clin Auton Res. 2006;16:228-234.
43. Liao D, Carnethon M, Evans GW, et al. Lower heart rate variability is associated with the development of coronary heart disease in individuals with diabetes: the atherosclerosis risk in communities (ARIC) study. Diabetes. 2002;51:3524-3531.
44. Costacou T, Huskey ND, Edmundowicz D, et al. Lower-extremity arterial calcification as a correlate of coronary artery calcification. Metab Clin Exp. 2006;55:1689-1696.
45. Kim JH, Kim DJ, Jang HC, et al. Epidemiology of micro-and macrovascular complications of type 2 diabetes in Korea. Diabetes Metab J. 2011;35:571-577.
46. Adler AI, Erqou S, Lima TA, et al. Association between glycated haemoglobin and the risk of lower extremity amputation in patients with diabetes mellitus-review and meta-analysis. Diabetologia. 2010;53:840-849.
47. Gonzalez ER, Oley MA. The management of lower-extremity diabetic ulcers. Manag Care Interface. 2000;13:80-87.